Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc > Kane Biotech Announces New Collaboration Agreements

<< Previous

Bullboard Posts

Next >>

Comment by StoneMan45on Feb 11, 2022 1:15pm

132 Views

Post# 34420894

RE:RE:Kane Biotech Announces New Collaboration Agreements

mirrirworldman take a look at this at 3:44 in...the slide from a prevoius/ old presentation plainly shows the prosthetic joints etc issue as a target. Also at the end at 7:00 gives some of the many targets that Kane is looking at.

https://ir.kanebiotech.com/overview-of-kane-wound-care

easily seen that Kane has many targets outside the 3 well known ones. Dr My Hedhammar [url=https://https://www.researchgate.net/profile/My-Hedhammar][/url]

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142364/

https://pubs.acs.org/doi/abs/10.1021/acsami.9b05531

https://onlinelibrary.wiley.com/doi/full/10.1002/mbo3.993

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec